Pre-earnings options volume in Capricor Therapeutics (CAPR) is normal with puts leading calls 19:5. Implied volatility suggests the market is anticipating a move near 14.8%, or $1.16, after results are released. Median move over the past eight quarters is 8.0%.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CAPR:
- Video: Nvidia, AMD said to pay U.S. 15% of revenue from China chip sales
- Capricor Therapeutics, Inc. (CAPR) Q2 Earnings Cheat Sheet
- Vinay Prasad returns to FDA as head of CBER
- Capricor Therapeutics announces Type A meeting scheduled with U.S. FDA
- Capricor Therapeutics call volume above normal and directionally bullish